Ever wondered what worms and a fine sense of smelling have to do with cancer diagnostic? If so, read this article about a new business partnership bringing a revolutionary new diagnostic technology called N-NOSE® to market.
About worms with a fine sense for smelling. Read More »
The Yokogawa Life Innovation Business recently developed in-house and through the acquisition of BioStinger Inc. new solutions for Single Cell Analysis (SCA). Today we would like to briefly introduce two new SCA research solutions.
Single-Cell Analysis: All cells are created equal, but are they? Read More »
At the end of 2019, the Yokogawa Life Innovation Business (LIB) reported on recent market strategies, product developments, and plans. Now at the beginning of the year 2021, even more great news occurred to be shared with our readers and customers in this business update article.
Further shaping the Life Innovation Business (LIB) Read More »
InSphero and their pharma and biotech partners were eager to exploit the full potential of 3D models through interrogation of specific cell population interactions and extraction of spatial and temporal information. High Content Analysis (HCA), specifically high content imaging, was recognized as a key technology to accomplish these technically challenging goals.
The Future of High Content Analysis is 3D Read More »
When a person thinks about Life Science usually topics like drug development, cancer research, genetic as well as 3D tissue engineering come to our mind. Probably one of the last things to consider would be space.
Life Science in Space Read More »
In order to drive the Yokogawa Life Innovation Business (LIB) forward in Europe, Dr. Gerd Heimlich joined Yokogawa as a new sales and market developer at Yokogawa Germany in 2019. He assumed responsibility for the Life Innovation Business (LIB).
The Yokogawa Life Innovation Business is on the move Read More »
